<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01848639</url>
  </required_header>
  <id_info>
    <org_study_id>ALCHEMIST</org_study_id>
    <secondary_id>RB 12-079</secondary_id>
    <nct_id>NCT01848639</nct_id>
  </id_info>
  <brief_title>ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial</brief_title>
  <acronym>ALCHEMIST</acronym>
  <official_title>ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST), Phase III b</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to etablish the effects of spironolactone in comparison to placebo on
      the composite endpoint of nonfatal Myocardial Infarction (MI) and acute coronary syndrome,
      hospitalization for heart failure, nonfatal stroke or cardiovascular-induced death. The
      primary endpoint will be the time to onset of the first incident.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  During a run-in period : Spironolactone will be initially administered per os at a 25 mg
           dose per two days in practice after the session, three times per week

        -  Patients will be randomized (spironolactone vs. placebo) and titrated over one month to
           a maximum single dose of 25 mg/d

        -  However if kalemia is greater than or equal to 5.5 mmol / l twice on this run-in period
           or on the day of randomization, patient won't be randomized.

        -  A pre-specified algorithm for the management of the risk of incident hyperkalemia will
           be followed, including dose adjustment, temporary cessation of study treatment, in
           addition to usual dietary measures and the use of chelating resins and low-potassium
           dialysis baths

        -  Patients will be followed for a mean of 2 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The time to onset of the first incident :non-fatal MI or acute coronary syndrome or hospitalization for heart failure or nonfatal stroke or cardiovascular (CV) death</measure>
    <time_frame>25 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The cumulate rate of non fatal MI or acute coronary syndrome, hospitalization for heart failure, nonfatal stroke or CV death</measure>
    <time_frame>25 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time to onset of death from i) any cause and ii) from a CV event and iii) from a non CV cause</measure>
    <time_frame>25 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time of survival without a major CV event (non fatal MI, acute coronary syndrome, hospitalization for heart failure, non-fatal stroke, cardiac arrest resuscitation)</measure>
    <time_frame>25 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of procedures related to stenosis or vascular access thrombosis for hemodialysis (HD)</measure>
    <time_frame>25 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of coronary or peripheral revascularizations (including lower limb amputations)</measure>
    <time_frame>25 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure and its inter visit variability</measure>
    <time_frame>25 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The occurrence of atrial fibrillation</measure>
    <time_frame>25 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hyperkalemia&gt; 6 mmol/l</measure>
    <time_frame>25 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimation of the effect of treatment on quality of life.</measure>
    <time_frame>25 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Ancillary study:establishment of a biological collection (serum bank and DNA biobank) for future biomarker studies</measure>
    <time_frame>25 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Ancillary study:morbimortality data</measure>
    <time_frame>3, 5 and 10 years of follow-up after the double-blind study</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">825</enrollment>
  <condition>End Stage Renal Failure on Dialysis</condition>
  <arm_group>
    <arm_group_label>Spironolactone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After a month in run-in period under 25 mg per 2 days of spironolactone administered per os in practice after dialysis session three times a week, patients will be randomized to spironolactone. The dose should be increased to 25 mg once daily and could be adjusted in using an algorithm used in the EPHESUS and EMPHASIS-HF trials.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After a month in run-in period under 25 mg per 2 days of spironolactone administered per os in practice after dialysis session three times a week, patients will be randomized to placebo. The dose should be increased to 25 mg once daily and could be adjusted in using an algorithm used in the EPHESUS and EMPHASIS-HF trials.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Spironolactone</intervention_name>
    <description>After a month in run-in period under 25 mg per 2 days of spironolactone administered per os in practice after dialysis session three times a week, patients will be randomized to spironolactone. The dose should be increased to 25 mg once daily and could be adjusted in using an algorithm used in the EPHESUS and EMPHASIS-HF trials.</description>
    <arm_group_label>Spironolactone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>After a month in run-in period under 25 mg per 2 days of spironolactone administered per os in practice after dialysis session three times a week, patients will be randomized to placebo. The dose should be increased to 25 mg once daily and could be adjusted in using an algorithm used in the EPHESUS and EMPHASIS-HF trials.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Health insurance beneficiary

          -  Men and women, on hemodialysis for at least 45 days for end-stage renal disease
             regardless of the aetiology including diabetes, with at least 3 hemodialysis sessions
             per week AND presenting at least one of following comorbidities or CV risk factors:

          -  left ventricular mass &gt; 130 g/m2 in men and 100 g/m2 in women measured during the
             twelve months preceding inclusion

          -  left ventricular ejection fraction &lt; 40% measured during the twelve months preceding
             inclusion

          -  diabetes

          -  history of Cardiovascular disease: coronary artery disease, symptomatic lower limb
             peripheral arterial disease, carotid or renal artery stenosis &gt; 50%, stroke,
             hospitalization for heart failure or CRP&gt; 5 mg / l for 3 months without infectious or
             neoplastic disease documented in progress

        Exclusion Criteria:

          -  history of hypersensitivity to spironolactone or galactose intolerance

          -  the Lapp lactase deficiency or malabsorption of glucose or galactose

          -  hyperkalemia &gt; 5.5 mmol/l during the two weeks prior to enrolment

          -  history of unscheduled hemodialysis for hyperkalemia during the last six months

          -  hospitalization for hyperkalemia during the last six months

          -  patients with imperative indication of a combination of ACEI and sartan or renin
             inhibitor (each being authorized separately), NSAIDS, Cox-2 inhibitors

          -  kidney transplant scheduled within the year

          -  symptomatic interdialytic hypotension

          -  acute systemic disease

          -  uncompensated hypothyroidism

          -  acute hyperthyroidism

          -  any prior or concomitant clinical condition compromising the inclusion, in the
             discretion of the investigator

          -  cardiac transplant

          -  severe uncontrolled arrhythmia

          -  stroke within 3 months prior to enrolment

          -  acute coronary syndrome in the previous month inclusion

          -  recent (1 month) or planned coronary revascularization by angioplasty

          -  recent (3 months) or planned cardiovascular surgery (excluding HD vascular access)

          -  non menopausal women or without effective contraceptive methods

          -  pregnancy, breastfeeding or planning a pregnancy within 2 years

          -  non compliance

          -  protected adult

          -  SBP &gt; 200 mmHg and/or DBP &gt; 110 mmHg

          -  Concomitant treatment can not be stopped by another potassium-sparing diuretic, a
             potassium supplements, AINS or Cox 2 inhibitors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Patrick ROSSIGNOL, Pr</last_name>
    <phone>+33383157320</phone>
    <email>p.rossignol@chu-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Erasme- Bruxelles</name>
      <address>
        <city>Bruxelles</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nortier Joëlle, Pr</last_name>
      <phone>25 55 33 34</phone>
      <phone_ext>0032</phone_ext>
      <email>Joelle.Nortier@erasme.ulb.ac.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Ardeche Nord</name>
      <address>
        <city>Annonay</city>
        <state>Ardeche</state>
        <zip>07100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric LEGRAND, PH</last_name>
    </contact>
    <investigator>
      <last_name>Eric Legrand, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriel CHOUKROUN, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Gabriel CHOUKROUN, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Avignon</name>
      <address>
        <city>Avignon</city>
        <zip>84000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Verhelst, PH</last_name>
    </contact>
    <investigator>
      <last_name>David Verhelst, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Marc Chalopin, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Marc Chalopin, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CH Boulogne Sur Mer</name>
      <address>
        <city>Boulogne Sur Mer</city>
        <zip>62321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Bataille, PH</last_name>
    </contact>
    <investigator>
      <last_name>Pierre Bataille, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yannick Le Meur, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Yannick Le Meur, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Caen</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Henri, PH</last_name>
    </contact>
    <investigator>
      <last_name>Patrick Henri, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Cahors</name>
      <address>
        <city>Cahors</city>
        <zip>46000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Etienne GED, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Etienne GED, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Chambéry</name>
      <address>
        <city>Chambéry</city>
        <zip>73000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques Fourcade, PH</last_name>
    </contact>
    <investigator>
      <last_name>Jacques Fourcade, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHPC Cherbourg</name>
      <address>
        <city>Cherbourg</city>
        <zip>50100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume Queffeulou, MD</last_name>
    </contact>
    <investigator>
      <last_name>Guillaume Queffeulou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AURAL Colmar</name>
      <address>
        <city>Colmar</city>
        <zip>68000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manfred Ismer</last_name>
    </contact>
    <investigator>
      <last_name>Manfred Ismer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopitaux Civils de Colmar</name>
      <address>
        <city>Colmar</city>
        <zip>68024</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehadji Maaz, PH</last_name>
    </contact>
    <investigator>
      <last_name>Mehadji Maaz, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>APHP Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>EL KAROUI Khalil, Dr</last_name>
      <phone>01 49 81 44 15</phone>
      <email>khalil.el-karoui@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Dijon Hôpital du Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel Rebidou, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Michel Rebidou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AGDUC Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Zaoui, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Philippe Zaoui, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AURAL Haguenau</name>
      <address>
        <city>Haguenau</city>
        <zip>67500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Dimitrov, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yves Dimitrov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Haguenau</name>
      <address>
        <city>Haguenau</city>
        <zip>67500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Dimitrov, PH</last_name>
    </contact>
    <investigator>
      <last_name>Yves Dimitrov, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>La Roche Sur Yon</name>
      <address>
        <city>La Roche Sur Yon</city>
        <zip>85000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion CHAPAL</last_name>
    </contact>
    <contact_backup>
      <email>marion.chapal@chd-vendee.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Polyclinique de Lagny</name>
      <address>
        <city>Lagny</city>
        <zip>77400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Clinique Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franck Bourdon, PH</last_name>
    </contact>
    <investigator>
      <last_name>Franck Bourdon, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Provot, PH</last_name>
    </contact>
    <investigator>
      <last_name>François Provot, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ALURAD Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carine ACHARD-HOTTELART, PH</last_name>
    </contact>
    <investigator>
      <last_name>Carine ACHARD-HOTTELART, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Essig, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Marie Essig, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHG Lisieux</name>
      <address>
        <city>Lisieux</city>
        <zip>14100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilie Kalbacher, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Emilie Kalbacher, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AURAL La Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myriam Pastural</last_name>
    </contact>
    <investigator>
      <last_name>Myriam Pastural</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH St Joseph-St Luc</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Villar, PH</last_name>
    </contact>
    <investigator>
      <last_name>Emmanuel Villar, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AURAL Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69008</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Walid Arkouche, PH</last_name>
    </contact>
    <investigator>
      <last_name>Walid Arkouche, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Bouchard</name>
      <address>
        <city>Marseille</city>
        <zip>13006</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe GIAIME</last_name>
    </contact>
    <investigator>
      <last_name>Philippe Giaime</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13008</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Adpc Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DUVAL-SABATIER DUVAL-SABATIER, Dr</last_name>
      <phone>0491293490</phone>
      <email>ariane.duval-sabatier@adpc.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHM Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion Sallee, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Marion Sallee, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique du pont Allant</name>
      <address>
        <city>Maubeuge</city>
        <zip>59604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Association de Metz</name>
      <address>
        <city>Metz</city>
        <zip>57000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>ALTIR Metz</name>
      <address>
        <city>Metz</city>
        <zip>58085</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Allard</last_name>
    </contact>
    <investigator>
      <last_name>Catherine Allard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHR Metz-Thionville</name>
      <address>
        <city>Metz</city>
        <zip>58085</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zead Tubail</last_name>
    </contact>
    <investigator>
      <last_name>Zead Tubail</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AURAL Mulhouse</name>
      <address>
        <city>Mulhouse</city>
        <zip>68100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Chantrel, PH</last_name>
    </contact>
    <investigator>
      <last_name>François Chantrel, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Mulhouse</name>
      <address>
        <city>Mulhouse</city>
        <zip>68100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Chantrel, PH</last_name>
    </contact>
    <investigator>
      <last_name>François Chantrel, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luc Frimat, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Luc Frimat, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric Lavainne, PH</last_name>
    </contact>
    <investigator>
      <last_name>Frédéric Lavainne, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nice</name>
      <address>
        <city>Nice</city>
        <zip>06002</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Esnault, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Vincent Esnault, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique St Georges</name>
      <address>
        <city>Nice</city>
        <zip>06100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Christophe Bendini</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Christophe Bendini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-HP La Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>AURA Paris 14ème</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>AURA Paris Plaisance</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maxime TOUZOT, MD</last_name>
    </contact>
    <contact_backup>
      <email>Maxime.Touzot@auraparis.org</email>
    </contact_backup>
    <investigator>
      <last_name>Maxime touzot, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hafedh Fessi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hefedh Fessi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-HP Necker</name>
      <address>
        <city>Paris</city>
        <zip>75743</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurélie Hummel, PH</last_name>
    </contact>
    <investigator>
      <last_name>Aurélie Hummel, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Mutualiste Montsouris</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MONGE Matthieu, Dr</last_name>
      <phone>01 56 61 66 03</phone>
      <email>Matthieu.Monge@imm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Solenne Pelletier, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Solenne Pelletier, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Rieu</last_name>
    </contact>
    <investigator>
      <last_name>Philippe Rieu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ARPDD Reims</name>
      <address>
        <city>Reims</city>
        <zip>51726</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Clavel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Pierre Clavel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AUB Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile Vigneau, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Cécile Vigneau, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ECHO Confluent</name>
      <address>
        <city>Reze</city>
        <zip>44402</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelo Testa, PH</last_name>
    </contact>
    <investigator>
      <last_name>Angelo Testa, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de Perharidy</name>
      <address>
        <city>Roscoff</city>
        <zip>29260</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia Mzoughi, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Sonia Mzoughi, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Roubaix</name>
      <address>
        <city>Roubaix</city>
        <zip>59056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Guincestre</last_name>
    </contact>
    <investigator>
      <last_name>Thomas Guincestre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de la Réunion Hôpital Félix Guyon</name>
      <address>
        <city>Saint Denis</city>
        <zip>97405</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Hélène Reboux, MD</last_name>
    </contact>
    <investigator>
      <last_name>Anne-Hélène Reboux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Mémorial Saint Lô</name>
      <address>
        <city>Saint Lô</city>
        <zip>50000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Aub Saint Malo</name>
      <address>
        <city>Saint Malo</city>
        <zip>35400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DOLLEY-HITZE Thibault, Dr</last_name>
      <phone>0299200140</phone>
      <email>thibault.dolley-hitze@aub-sante.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ch Saint Malo</name>
      <address>
        <city>Saint-Malo</city>
        <zip>35403</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric RENAUDINEAU</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHG St Brieuc</name>
      <address>
        <city>St Brieuc</city>
        <zip>22000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rehouni Boulahrouz, PH</last_name>
    </contact>
    <investigator>
      <last_name>Rehouni Boulahrouz, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH St Maurice</name>
      <address>
        <city>St Maurice</city>
        <zip>94410</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>AURAL St Anne (AURAL Strasbourg)</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine GARSTKA</last_name>
    </contact>
    <contact_backup>
      <email>a.garstka@ghsv.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Hannedouche, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Thierry Hannedouche, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AURAL Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristian Kunz, PH</last_name>
    </contact>
    <investigator>
      <last_name>Kristian Kunz, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lionel Rostaing, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Lionel Rostaing, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Tours</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maud Francois, PH</last_name>
    </contact>
    <investigator>
      <last_name>Maud Francois, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Troyes</name>
      <address>
        <city>Troyes</city>
        <zip>10003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bénédicte Levy</last_name>
    </contact>
    <investigator>
      <last_name>Bénédicte Levy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Valenciennes</name>
      <address>
        <city>Valenciennes</city>
        <zip>59322</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary-Jane Guerry</last_name>
    </contact>
    <investigator>
      <last_name>Mary-Jane Guerry</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ALTIR Nancy</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <zip>54504</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nelly Castin, PH</last_name>
    </contact>
    <investigator>
      <last_name>Nelly Castin, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Privés de Metz- Hôpital Robert Schuman</name>
      <address>
        <city>Vantoux</city>
        <zip>57070</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>CH Verdun</name>
      <address>
        <city>Verdun</city>
        <zip>55107</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal Bindi, PH</last_name>
    </contact>
    <investigator>
      <last_name>Pascal Bindi, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Vichy</name>
      <address>
        <city>Vichy</city>
        <zip>03201</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier Aguilera</last_name>
    </contact>
    <investigator>
      <last_name>Didier Aguilera</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Princesse Grace</name>
      <address>
        <city>Monaco</city>
        <country>Monaco</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ROBINO Christophe, Dr</last_name>
      <phone>00377 97 98 97 78</phone>
      <email>christophe.robino@chpg.mc</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Monaco</country>
  </location_countries>
  <removed_countries>
    <country>Guadeloupe</country>
    <country>Martinique</country>
    <country>Switzerland</country>
  </removed_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2013</study_first_submitted>
  <study_first_submitted_qc>May 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2013</study_first_posted>
  <last_update_submitted>November 20, 2017</last_update_submitted>
  <last_update_submitted_qc>November 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic kidney disease</keyword>
  <keyword>end-stage renal disease</keyword>
  <keyword>hemodialysis (ESRD)</keyword>
  <keyword>cardiovascular morbimortality</keyword>
  <keyword>aldosterone antagonist</keyword>
  <keyword>spironolactone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spironolactone</mesh_term>
    <mesh_term>Mineralocorticoid Receptor Antagonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

